Ameritox

BALTIMORE, May 23, 2013 /PRNewswire/ -- Ameritox, the nation's leader in pain medication monitoring, has been selected by Progressive Medical, Inc. to become part of its Urine Drug Monitoring (UDM) network to help clients manage pharmacy costs and improve the clinical outcomes for injured workers. Progressive Medical, a ... read more

BALTIMORE, April 12, 2013 /PRNewswire/ -- Ameritox, one of the nation's leaders in pain medication monitoring, announced new research today showing a correlation between positive marijuana tests and higher rates of potential prescription drug non-adherence among chronic pain medication users. The research was presented at the American ... read more

BALTIMORE, Jan. 31, 2013 /PRNewswire/ -- Ameritox(SM), the nation's leader in Pain Medication Monitoring Solutions®, continues to address the prescription medication abuse crisis by educating lawmakers, physicians and chronic pain patients about the importance of ensuring that patients have access to needed medications, while keeping ... read more

BALTIMORE, Jan. 14, 2013 /PRNewswire/ -- Ameritox(SM) announced today that it is sponsoring a series of webinars this month aimed at educating physicians about a set of Kentucky laws intended to curb prescription drug misuse and abuse. Kentucky has an on-going problem with misuse, abuse and diversion ... read more

BALTIMORE, Jan. 9, 2013 /PRNewswire/ -- Ameritox(®), the nation's leader in medication monitoring, has become a founding member of the Coalition for Excellence in Medication Monitoring (CEMM). The coalition, consisting of some of the nation's leading medication monitoring companies, was formed to advance clinical treatment and ... read more

WINSTON SALEM, N.C., Dec. 4, 2012 /PRNewswire/ -- Wake Forest University and Ameritox, Ltd. today announced that Ameritox is supporting research at Wake Forest that could break new ground in developing technologies for medication monitoring and toxicology testing. "Ameritox, the nation's leader in medication monitoring with ... read more